SynthesisBMC cancer2024

PD-1/PD-L1 immune checkpoint inhibitors in the treatment of unresectable locally advanced or metastatic triple negative breast cancer: a meta-analysis on their efficacy and safety.

Zuxiu Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.